Global venture capital firm with a focus on early and growth-stage technology companies.
Verified emails & LinkedIn for founders across this portfolio.
BioSimulytics develops AI-powered software for drug researchers.
Hooke Bio is a biotechnology company providing engineering solutions for the analysis of 3D microtissues for preclinical drug development
Picterus has developed a smartphone application that can screen for neonatal jaundice with high accuracy.
Cephalgo, based in Strasbourg, France, measures disease progression from speech for CNS clinical trials. Speech readings shift when phones or their software change mid-trial; Cephalgo keeps them stable by recalibrating from the audio. It also reviews recorded rater interviews (Trial QC).
LUBIS EDA offers formal verification software and services for a bug-free semiconductor development.
Molecular Attraction is a bio-attractant discovery company.
C2C-NewCap has developed a breakthrough supercapacitor contributing towards more sustainable mobility.
With everything we do, we aim to harness sustainable energy in order to energize the future.
RAYDIAX is a manufacturing company which makes therapy-assist CT systems that enable minimally invasive interventions.
Novobiom specializes in unblocking the power of fungi to revolutionize waste management and build a sustainable future.
UniSCool is an IT consulting firm that offers energy efficiency, sustainability, heat transfer, and thermal management services.
ArgusEye is a biotechnology company that provides sensor solutions for real-time detection of biological systems and processes.
Fluid Wire Robotics provides a novel mechanical layout for a hydraulic transmission system that is robotic.
Zaitra helps in reducing costs in data transmission along with spacecraft onboard and artificial intelligence services.
CrannMed is developing resorbable embolic particles and a custom delivery catheter for the treatment of Knee Osteoarthritis.
Pixel Photonics manufactures scalable single-photon detectors for applications like secure quantum communication.
N-Ink provides n-type ink which is compatible with Printed Electronics, the Internet of Things, and Bioelectronics.
Adaptavate is focussing on developing and commercialising material solutions that disrupt the conventional construction industry.
PlantSea manufactures and develops sustainable products using seaweed and aquaculture materials.
Coramaze is a clinical stage venture backed start-up, filling the cardiac gap in heart valve repair
MECAWARE mission is to speed up strategic autonomy thanks to resource circularity and the intelligence of the material cycle.
Pregnolia developed an innovative system to accurately assess the stiffness of the cervical tissue of pregnant and non-pregnant women.
Vexlum Provider of high-brightness semiconductor laser technology.
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system.
EIC Accelerator has invested in 337 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EIC Accelerator's top investment sectors include Biotechnology, Health Care, Medical Device, Electronics, Artificial Intelligence (AI). The firm invests across 42 different industry categories.
Among tracked funding rounds, UniverCell Holding GmbH received $34.8M in a Series B round. EIC Accelerator's total known invested capital is $1.9B.
EIC Accelerator's average investment size is $5.6M across its portfolio of 337 companies.
Recent EIC Accelerator portfolio additions include BioSimulytics, Hooke Bio, Picterus, Cephalgo, LUBIS EDA. These companies were founded in 2020 or later.